Viewing Study NCT01311518

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:47 AM
Ignite Modification Date: 2026-03-02 @ 4:02 PM
Study NCT ID: NCT01311518
Status: WITHDRAWN
Last Update Posted: 2021-09-22
First Post: 2011-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
Sponsor: RegeneRx Biopharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myocardial Infarction View
None ST Elevation Myocardial Infarction View
None STEMI View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Thymosin Beta 4 View
None Thymosin β4 (Tβ4) Injectable Solution View
None RGN-352 View